Title : The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis.

Pub. Date : 2002 Apr

PMID : 12018828






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rivastigmine is a potent inhibitor of AChE and BuChE and has demonstrated broad benefits across the severity of AD and across the cognitive, functional and behavioural domains of AD. Rivastigmine acetylcholinesterase (Cartwright blood group) Homo sapiens
2 These benefits may reflect the inhibition of both AChE and BuChE, as demonstrated by significant correlations between cognitive improvements and cholinesterase inhibition in rivastigmine-treated patients with AD. Rivastigmine acetylcholinesterase (Cartwright blood group) Homo sapiens